Welcome to our dedicated page for Camtek SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Camtek Ltd (CAMT) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures as a foreign private issuer. Camtek files an Annual Report on Form 20-F and furnishes interim information on Form 6-K, including press releases, unaudited financial statements, and operating and financial review documents. These filings provide detailed insight into its business as a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry.
Through recent Form 6-K reports, investors can review Camtek’s quarterly and year-to-date financial results, including GAAP and non-GAAP figures, segment commentary, and management discussion of drivers such as advanced packaging, Memory and HBM, and high-performance computing for AI applications. The company also explains its use of non-GAAP measures that exclude share-based compensation, acquisition-related expenses, and, in some periods, expenses related to the extinguishment of convertible notes.
Filings further document Camtek’s capital structure activity. A Form 6-K dated September 16, 2025, describes the closing of an aggregate $500 million principal amount of 0.00% Convertible Senior Notes due 2030, issued under an indenture and positioned as senior unsecured obligations. The filing outlines key terms such as maturity, conversion mechanics, redemption and repurchase provisions, and the intended use of proceeds, including repurchase of existing 0% convertible notes due 2026 and general corporate purposes.
On Stock Titan, these SEC documents are paired with AI-powered tools that help readers navigate complex items such as Form 6-K exhibits, indenture summaries, and reconciliations between GAAP and non-GAAP performance. Users can quickly locate quarterly results, capital markets transactions, and risk factor discussions that Camtek references in its filings without reading every line of each report.
CAMT reported insider sales: Orit Geva-Dvash sold 2,239 ordinary shares on
CAMT submission of Form 144 reporting proposed or past resale activity in ordinary shares by a holder. The filing lists two groups of Restricted Stock Units granted on
Form 144 notice for proposed resale of ordinary shares. The filing names Oppenheimer & Co. Inc. as the broker and indicates 150 ordinary shares tied to an Employee Stock Option Plan are to be sold on 02/25/2026 with cash upon exercise as the method. The excerpt also reports that Ben Arie Mordechay sold 3,908 ordinary shares on 12/03/2025 for $466,715.25.
CAMT (ordinary shares): Moshe Eisenberg filed a Form 144 notifying a proposed sale of ordinary shares. The filing shows recent dispositions: 4,045 shares on 11/24/2025 for $398,988.10, 2,328 shares on 12/08/2025 for $274,533.72, 619 shares on 12/10/2025 for $74,280.00, and 3,369 shares on 02/19/2026 for $523,433.11.
CAMT reported insider sale activity by director Orit Geva-Dvash. The filing lists two dispositions of Ordinary shares:
The transactions are presented on a Form 144 notification of proposed sale under securities rules; the entries identify the broker as Oppenheimer & Co. Inc. and the exchange as NASDAQ.
Ramy Langer reported a sale of 1,512 ordinary shares on
The excerpt lists shares outstanding of 45,449,306 as of 02/19/2026 as a context figure.
Camtek Ltd. reporting proposed and completed insider sales of ordinary shares by Moshe Eisenberg. The filing lists three completed transactions: 4,045 shares on
Camtek Ltd. reported record results for 2025, with revenues rising 16% to
Non-GAAP net income grew to
Migdal Insurance & Financial Holdings Ltd. has filed a beneficial ownership report showing a 5.1% stake in Camtek Ltd. The filing states Migdal and its subsidiaries collectively hold 2,332,037 ordinary shares, with no sole voting or dispositive power, only shared authority.
The shares are held through various Migdal subsidiaries for the benefit of policyholders, pension and provident fund members, mutual fund investors, portfolio clients and proprietary (“nostro”) accounts. Migdal and its subsidiaries formally disclaim forming a group and any beneficial ownership beyond their actual economic interest.
The signatories also certify that the Camtek shares were not acquired, and are not held, to change or influence control of Camtek, but as part of investment management activities.
Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership of 3,167,997 Camtek Ltd ordinary shares, representing 6.9% of the class as of 12/31/2025. Wasatch has sole voting power over 2,139,557 shares and sole dispositive power over 3,167,997 shares.
The firm states the Camtek shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Camtek. The filing is signed by CEO Mike Yeates on behalf of Wasatch Advisors.